RCSB PDB Advisory Committee

Recognized experts in fields, including but not limited to, structural biology, cell and molecular biology, computational biology, information technology, and education serve as advisors to the RCSB PDB. These scientists are drawn from both academia and industry (Terms of Reference PDF).

The current members of the RCSB PDB Advisory Committee include:

Paul Adams (Chair), Lawrence Berkeley National Laboratory
Peter Andolfatto, Columbia University
Bridget Carragher, New York Structural Biology Center
Wah Chiu, Stanford University
Kirk L. Clark, Novartis Institutes for BioMedical Research
Robert Darnell, The Rockefeller University
Roland L. Dunbrack, Fox Chase Cancer Center
Paul Falkowski, Rutgers, The University of New Jersey
Thomas E. Ferrin, University of California, San Francisco
Kevin Gardner, City University of New York
Mandë Holford, Hunter College
Catherine E. Peishoff, GlaxoSmithKline
Seung Yon Rhee, Carnegie Institution for Science
Torsten Schwede, University of Basel
Lance Stewart, University of Washington’s School of Medicine
Takita Sumter, Winthrop University

Past members have included Frank Allen (CCDC), Edward Baker (University of Auckland), Manju Bansal (Indian Institute of Science), Judith Blake (The Jackson Laboratory), Stephen Burley (SGX), Jack Chirikjian (Georgetown University), Paul Craig (Rochester Institute of Technology), Juli Feigon (University of California Los Angeles), Nobuhiro Go (Japan Atomic Energy Agency), Barry Honig (Columbia University), Andrzej Joachimiak (Argonne National Lab), Robert Kaptein (Utrecht University), Sung-Hou Kim (Lawrence Berkeley National Lab), Ann Palmenberg (University of Wisconsin Madison), Anthony Pawson (Mount Sinai Hospital), Seth Pinsky (MDL Information Systems), Andrej Sali (University of California, San Francisco), David Searls (GlaxoSmithKline), Jill Trewhella (The University of Sydney), Judith Voet (Swarthmore College), Cynthia Wolberger (Johns Hopkins University School of Medicine), Cathy Wu (University of Delaware).